Lee Sang Seop, Cha Eun-Young, Jung Hyun-Ju, Shon Ji-Hong, Kim Eun-Young, Yeo Chang-Woo, Shin Jae-Gook
Pharmacogenimics Research Center, Inje University College of Medicine, Busanjin-gu, Busan, Korea.
Hepatology. 2008 Aug;48(2):635-45. doi: 10.1002/hep.22396.
Hepatocyte nuclear factor-4 alpha (HNF4A) is an essential transcriptional regulator for many genes that are expressed preferentially in the liver. Among the important functions of the liver is drug metabolism in response to xenobiotic exposure. Recent studies have suggested that HNF4A regulates the expression of cytochrome P450 (CYP), including CYP2D6 and CYP3A4, which show large individual variations in their activities. To understand the genetic factors that influence individual CYP activities, a genetic variant of HNF4A and the effects of genetic variants of HNF4A on CYP activity were investigated. Here, we report the identification of a novel coding variant of HNF4A that influences CYP2D6 activity in humans. After direct sequencing, a polymorphism search revealed the HNF4A G60D variant in Koreans. This variant was unable to bind to the recognition site in the CYP2D6 promoter and therefore lacked the regulatory function for this gene. Human liver specimens with the heterozygous HNF4A G60D genotype showed a tendency toward lower levels of CYP2D6 activity than the wild-type genotype in the same genetic background of CYP2D6. Furthermore, human subjects with the HNF4A G60D genotype tended to have lower CYP2D6 activity than those with the wild-type HNF4A. The HNF4A G60D variant was detected at low frequency in Asian populations, including Koreans, Chinese, and Vietnamese, and was not found in Africans or Caucasians.
This is the first report to show that the genetic polymorphism of liver-enriched nuclear receptor HNF4A influences downstream CYP2D6 function in human subjects.
肝细胞核因子4α(HNF4A)是许多在肝脏中优先表达的基因的关键转录调节因子。肝脏的重要功能之一是对外源物质暴露做出反应进行药物代谢。最近的研究表明,HNF4A调节细胞色素P450(CYP)的表达,包括CYP2D6和CYP3A4,它们的活性存在很大的个体差异。为了了解影响个体CYP活性的遗传因素,研究了HNF4A的一种基因变异及其对CYP活性的影响。在此,我们报告鉴定出一种影响人类CYP2D6活性的HNF4A新编码变异。直接测序后,多态性搜索在韩国人中发现了HNF4A G60D变异。该变异无法与CYP2D6启动子中的识别位点结合,因此缺乏对该基因的调节功能。在相同CYP2D6遗传背景下,具有杂合HNF4A G60D基因型的人类肝脏标本显示出CYP2D6活性水平低于野生型基因型的趋势。此外,具有HNF4A G60D基因型的人类受试者的CYP2D6活性往往低于具有野生型HNF4A的受试者。HNF4A G60D变异在包括韩国人、中国人和越南人在内的亚洲人群中低频检出,在非洲人或白种人中未发现。
这是首次报道肝脏富集核受体HNF4A的基因多态性影响人类受试者下游CYP2D6功能。